|
Market Closed -
NYSE
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.080 USD | -1.82% |
|
-2.70% | -35.33% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
NYSE
LCTX 1.080 $
-1.82%
579K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 1.080USD | -1.82% | 579K $ | ||
CBOE
| LCTX | 1.085USD | -0.91% | 19.64K $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 332.60ILa | -0.86% | 393K ILa | |
|
Deutsche Boerse AG
| BT3 | 0.9180EUR | -1.29% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9190EUR | -0.65% | 0 € | |
|
Tradegate
| BT3 | 0.9350EUR | -0.74% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9520EUR | 0.00% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 31/08/2026 | 01/09/2026 | 02/09/2026 | 03/09/2026 | 04/09/2026 | |
|---|---|---|---|---|---|
| Last | US$1.100 | US$1.080 | US$1.110 | US$1.100 | US$1.080 |
| Volume | 583,452 | 905,661 | 675,975 | 917,013 | 535,725 |
| Change | -0.90% | -1.82% | +2.78% | -0.90% | -1.82% |
| Opening | US$1.110 | US$1.100 | US$1.080 | US$1.110 | US$1.090 |
| High | US$1.128 | US$1.120 | US$1.135 | US$1.120 | US$1.105 |
| Low | US$1.100 | US$1.080 | US$1.080 | US$1.085 | US$1.080 |
Performance
| 1 day | -1.82% | ||
| 1 week | -2.70% | ||
| Current month | -1.82% | ||
| 1 month | -3.57% | ||
| 3 months | -10.74% | ||
| 6 months | -44.62% | ||
| Current year | -35.33% | ||
| 1 year | -10.00% | ||
| 3 years | -19.40% | ||
| 5 years | -61.29% | ||
| 10 years | -62.11% |
Volumes
marketsDaily volume
535,726
Estimated daily volume
535,726
Avg. Volume 20 sessions
887,125
Daily volume ratio
0.6
Avg. Volume 20 sessions USD
958,095
Record volume 1
23,661,485
Record volume 2
22,539,712
Record volume 3
17,430,494
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
278,198,210
Net sales (USD)
14,556,000
Number of employees
75
Sales / Employee (USD)
194,080
Free-Float
95.14 %
Free-Float capitalization (USD)
264,677,733
Average Daily Capital Traded
0.34%
Indicators
Moving average 5 days
1.1
Moving average 20 days
1.1
Moving average 50 days
1.155
Moving average 100 days
1.259
Price spread / (MMA5)
+1.85%
Price spread / (MMA20)
+1.81%
Price spread / (MMA50)
+6.98%
Price spread / (MMA100)
+16.56%
RSI 9 days
51.37
RSI 14 days
49.37
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.82% | -2.70% | -10.00% | -19.40% | 278M | |
| -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | |
| -0.40% | +1.03% | +439.20% | +499.20% | 45.2B | |
| -1.42% | +2.30% | +45.46% | +19.36% | 44.71B | |
| -1.22% | -2.31% | +12.40% | +71.48% | 41.24B | |
| +0.53% | -1.36% | +16.04% | +48.23% | 33.08B | |
| -0.21% | +9.14% | - | - | 17.81B | |
| -0.35% | -1.56% | +22.59% | +116.19% | 16.56B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | |
| -1.65% | -1.03% | +77.75% | +37.63% | 14B | |
| Average | -1.01% | -0.07% | +68.60% | +90.58% | 27.8B | |
| Weighted average by Cap. | -1.04% | +0.25% | +94.24% | +121.29% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
67e5002006dcdc4514f891a0e9f5889.flivgKlALmfbCMIJS_OA_SAIkCgM8akzjW2ptgKWzH8.ITXc5tAvZjKZZZF-LqK5lmtJ9x1IuNtd7AP98DryhjYJLOvQ3Q56Kaxxhw
| Date | Price | Volume | Total |
|---|---|---|---|
| 21:00:00 | 1.080 | 22,506 | 474,033 |
| 20:59:59 | 1.080 | 195 | 451,527 |
| 20:59:59 | 1.085 | 139 | 451,332 |
| 20:59:59 | 1.085 | 126 | 451,193 |
| 20:59:58 | 1.080 | 100 | 451,067 |
| 20:59:57 | 1.085 | 100 | 450,967 |
| 20:59:57 | 1.085 | 100 | 450,867 |
| 20:59:56 | 1.085 | 100 | 450,767 |
| 20:59:55 | 1.085 | 100 | 450,667 |
| 20:59:54 | 1.080 | 100 | 450,567 |
Price Extremes
| 1 week | 1.08 |  | 1.14 |
| 1 month | 1.04 | | 1.18 |
| Current year | 1 | | 1.98 |
| 1 year | 1 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.8 |
| 10 years | 0.37 | | 4 |
Monthly variations
Annual variations
| 2026 | -35.33% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
